These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 33478107)

  • 21. Endothelial cell dysfunction, coagulation, and angiogenesis in coronavirus disease 2019 (COVID-19).
    Norooznezhad AH; Mansouri K
    Microvasc Res; 2021 Sep; 137():104188. PubMed ID: 34022205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19: Between Past and Present.
    Assaf AM; Haddadin RN; Akour AA
    Viral Immunol; 2021 Apr; 34(3):145-157. PubMed ID: 33017280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SARS-CoV-2/ACE2 Interaction Suppresses IRAK-M Expression and Promotes Pro-Inflammatory Cytokine Production in Macrophages.
    Pantazi I; Al-Qahtani AA; Alhamlan FS; Alothaid H; Matou-Nasri S; Sourvinos G; Vergadi E; Tsatsanis C
    Front Immunol; 2021; 12():683800. PubMed ID: 34248968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines and Chemokines in SARS-CoV-2 Infections-Therapeutic Strategies Targeting Cytokine Storm.
    Pum A; Ennemoser M; Adage T; Kungl AJ
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33445810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ocular Pathology and Occasionally Detectable Intraocular Severe Acute Respiratory Syndrome Coronavirus-2 RNA in Five Fatal Coronavirus Disease-19 Cases.
    Reinhold A; Tzankov A; Matter MS; Mihic-Probst D; Scholl HPN; Meyer P
    Ophthalmic Res; 2021; 64(5):785-792. PubMed ID: 33472206
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung Expression of Human Angiotensin-Converting Enzyme 2 Sensitizes the Mouse to SARS-CoV-2 Infection.
    Han K; Blair RV; Iwanaga N; Liu F; Russell-Lodrigue KE; Qin Z; Midkiff CC; Golden NA; Doyle-Meyers LA; Kabir ME; Chandler KE; Cutrera KL; Ren M; Monjure CJ; Lehmicke G; Fischer T; Beddingfield B; Wanek AG; Birnbaum A; Maness NJ; Roy CJ; Datta PK; Rappaport J; Kolls JK; Qin X
    Am J Respir Cell Mol Biol; 2021 Jan; 64(1):79-88. PubMed ID: 32991819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Coronavirus infection: An immunologists' perspective.
    De Sanctis JB; García AH; Moreno D; Hajduch M
    Scand J Immunol; 2021 Jun; 93(6):e13043. PubMed ID: 33783027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disequilibrium between the classic renin-angiotensin system and its opposing arm in SARS-CoV-2-related lung injury.
    Sarzani R; Giulietti F; Di Pentima C; Giordano P; Spannella F
    Am J Physiol Lung Cell Mol Physiol; 2020 Aug; 319(2):L325-L336. PubMed ID: 32639866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury.
    Nicosia RF; Ligresti G; Caporarello N; Akilesh S; Ribatti D
    Am J Pathol; 2021 Aug; 191(8):1374-1384. PubMed ID: 34033751
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of COVID-19 inflammatory pathogenesis from the therapeutic perspective.
    Lee C; Choi WJ
    Arch Pharm Res; 2021 Jan; 44(1):99-116. PubMed ID: 33398692
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential association between PARP14 and SARS-CoV-2 infection (COVID-19).
    Tauber AL; Schweiker SS; Levonis SM
    Future Med Chem; 2021 Mar; 13(6):587-592. PubMed ID: 33467912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokine storm in COVID-19: from viral infection to immune responses, diagnosis and therapy.
    Jiang Y; Rubin L; Peng T; Liu L; Xing X; Lazarovici P; Zheng W
    Int J Biol Sci; 2022; 18(2):459-472. PubMed ID: 35002503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stem cell therapy for severe COVID-19.
    Shi L; Wang L; Xu R; Zhang C; Xie Y; Liu K; Li T; Hu W; Zhen C; Wang FS
    Signal Transduct Target Ther; 2021 Sep; 6(1):339. PubMed ID: 34497264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The pro-inflammatory cytokines in COVID-19 pathogenesis: What goes wrong?
    Darif D; Hammi I; Kihel A; El Idrissi Saik I; Guessous F; Akarid K
    Microb Pathog; 2021 Apr; 153():104799. PubMed ID: 33609650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
    Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
    J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review.
    Kulanthaivel S; Kaliberdenko VB; Balasundaram K; Shterenshis MV; Scarpellini E; Abenavoli L
    Rev Recent Clin Trials; 2021; 16(2):138-145. PubMed ID: 32940187
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower Gene Expression of Angiotensin Converting Enzyme 2 Receptor in Lung Tissues of Smokers with COVID-19 Pneumonia.
    Lunardi F; Fortarezza F; Vedovelli L; Pezzuto F; Boscolo A; Rossato M; Vettor R; Cattelan AM; Del Vecchio C; Crisanti A; Navalesi P; Gregori D; Calabrese F
    Biomolecules; 2021 May; 11(6):. PubMed ID: 34073591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Pro-Inflammatory Chemokines CXCL9, CXCL10 and CXCL11 Are Upregulated Following SARS-CoV-2 Infection in an AKT-Dependent Manner.
    Callahan V; Hawks S; Crawford MA; Lehman CW; Morrison HA; Ivester HM; Akhrymuk I; Boghdeh N; Flor R; Finkielstein CV; Allen IC; Weger-Lucarelli J; Duggal N; Hughes MA; Kehn-Hall K
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34205098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific inhibition of the NLRP3 inflammasome suppresses immune overactivation and alleviates COVID-19 like pathology in mice.
    Zeng J; Xie X; Feng XL; Xu L; Han JB; Yu D; Zou QC; Liu Q; Li X; Ma G; Li MH; Yao YG
    EBioMedicine; 2022 Jan; 75():103803. PubMed ID: 34979342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.